#185 Damon Rasheed & Saurabh Jain: Achieving Up to 90% Accuracy in Predicting Drug Clinical Trial Outcomes with Opyl's Trialkey.ai

Eye On A.I.

This episode is sponsored by Netsuite by Oracle, the number one cloud financial system, streamlining accounting, financial management, inventory, HR, and more.

NetSuite is offering a one-of-a-kind flexible financing program. Head to https://netsuite.com/EYEONAI to know more.

Unlock the secrets of clinical trial predictions with Saurabh Jain and Damon Rasheed from Opyl & TrialKey.ai on this episode of Eye on AI.

In today’s discussion, delve into how TrialKey's pioneering AI model can predict the success of clinical trials with astonishing accuracy—about 90%. Learn about the innovative use of over 400,000 past trials to enhance the precision and efficiency of new pharmaceutical trials. Saurabh and Damon share how their technology not only predicts outcomes but also optimizes trial design, saving substantial time and resources in the drug development process.

The episode also covers the sophisticated data processing techniques employed by TrialKey, including natural language processing to extract vital variables from complex datasets, and the strategic use of these insights to improve trial designs. Discover the implications of poorly designed trials and how AI can revolutionize their structure for better success rates.

Tune in to gain a deeper understanding of how AI and machine learning are transforming the pharmaceutical landscape, making clinical trials more predictive and efficient. Saurabh and Damon’s expertise offers a glimpse into the future of medical research and investment, emphasizing the role of AI in enhancing decision-making and resource allocation in healthcare.

Remember to like, subscribe, and hit the notification bell to keep up with the latest innovations and discussions reshaping the future of artificial intelligence and healthcare.

Stay Updated:

Craig Smith Twitter: https://twitter.com/craigss

Eye on A.I. Twitter: https://twitter.com/EyeOn_AI